000 01630 a2200445 4500
005 20250518084217.0
264 0 _c20201023
008 202010s 0 0 eng d
022 _a1550-6606
024 7 _a10.4049/jimmunol.1900983
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiki, Haruka
245 0 0 _a4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_c04 2020
300 _a1892-1903 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _a4-1BB Ligand
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aFemale
650 0 4 _aImiquimod
_xpharmacology
650 0 4 _aInflammation
_xmetabolism
650 0 4 _aInterleukin-17
_xmetabolism
650 0 4 _aMacrophage Activation
_xdrug effects
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPsoriasis
_xchemically induced
650 0 4 _aRAW 264.7 Cells
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSkin
_xdrug effects
650 0 4 _aT-Lymphocytes, Regulatory
_xdrug effects
700 1 _aHan, Kyung Ho
700 1 _aScott, David
700 1 _aCroft, Michael
700 1 _aKang, Young Jun
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 204
_gno. 7
_gp. 1892-1903
856 4 0 _uhttps://doi.org/10.4049/jimmunol.1900983
_zAvailable from publisher's website
999 _c30618593
_d30618593